RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy

Abstract Background Hepatic fibrosis (HF) is a pathological process caused by excessive accumulation of extracellular matrix caused by a series of causes, leading to the formation of fiber scar. RNA methylation is a newly discovered epigenetic modification that exists widely in eukaryotes and prokar...

Full description

Bibliographic Details
Main Authors: Chenglong Cheng, Yajie Wu, Xin Wang, Qiuyun Xue, Yurong Huang, Faxue Liao, Xiao Wang, Qiangjun Duan, Chenggui Miao
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Cell & Bioscience
Subjects:
Online Access:https://doi.org/10.1186/s13578-023-01066-8
_version_ 1797784375167811584
author Chenglong Cheng
Yajie Wu
Xin Wang
Qiuyun Xue
Yurong Huang
Faxue Liao
Xiao Wang
Qiangjun Duan
Chenggui Miao
author_facet Chenglong Cheng
Yajie Wu
Xin Wang
Qiuyun Xue
Yurong Huang
Faxue Liao
Xiao Wang
Qiangjun Duan
Chenggui Miao
author_sort Chenglong Cheng
collection DOAJ
description Abstract Background Hepatic fibrosis (HF) is a pathological process caused by excessive accumulation of extracellular matrix caused by a series of causes, leading to the formation of fiber scar. RNA methylation is a newly discovered epigenetic modification that exists widely in eukaryotes and prokaryotes and plays a crucial role in the pathogenesis of many diseases. Results The occurrence and development of HF are regulated by many factors, including excessive deposition of extracellular matrix, activation of hepatic stellate cells, inflammation, and oxidative stress. RNA methylations of different species have become a crucial regulatory mode of transcript expression, And participate in the pathogenesis of tumors, nervous system diseases, autoimmune diseases, and other diseases. In addition, there are five common types of RNA methylation, but only m6A plays a crucial regulatory role in HF. The pathophysiological regulation of m6A on HF is achieved by the combination of the methylated transferase, demethylated enzyme, and methylated reading protein. Conclusions RNA methylated methyltransferase, demethylase, and reading protein extensively affect the pathological mechanism of HF, which may be a new therapeutic and diagnostic target, representing a new class of therapeutic strategies.
first_indexed 2024-03-13T00:39:58Z
format Article
id doaj.art-b5d2f69209b344ffbb7b29cdd82d9cfb
institution Directory Open Access Journal
issn 2045-3701
language English
last_indexed 2024-03-13T00:39:58Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Cell & Bioscience
spelling doaj.art-b5d2f69209b344ffbb7b29cdd82d9cfb2023-07-09T11:26:14ZengBMCCell & Bioscience2045-37012023-07-0113111410.1186/s13578-023-01066-8RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategyChenglong Cheng0Yajie Wu1Xin Wang2Qiuyun Xue3Yurong Huang4Faxue Liao5Xiao Wang6Qiangjun Duan7Chenggui Miao8Department of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Orthopaedics, The First Affiliated Hospital, Anhui Medical UniversityDepartment of Clinical Nursing, School of Nursing, Anhui University of Chinese MedicineDepartment of Experimental (Practical Training) Teaching Center, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineDepartment of Pharmacology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese MedicineAbstract Background Hepatic fibrosis (HF) is a pathological process caused by excessive accumulation of extracellular matrix caused by a series of causes, leading to the formation of fiber scar. RNA methylation is a newly discovered epigenetic modification that exists widely in eukaryotes and prokaryotes and plays a crucial role in the pathogenesis of many diseases. Results The occurrence and development of HF are regulated by many factors, including excessive deposition of extracellular matrix, activation of hepatic stellate cells, inflammation, and oxidative stress. RNA methylations of different species have become a crucial regulatory mode of transcript expression, And participate in the pathogenesis of tumors, nervous system diseases, autoimmune diseases, and other diseases. In addition, there are five common types of RNA methylation, but only m6A plays a crucial regulatory role in HF. The pathophysiological regulation of m6A on HF is achieved by the combination of the methylated transferase, demethylated enzyme, and methylated reading protein. Conclusions RNA methylated methyltransferase, demethylase, and reading protein extensively affect the pathological mechanism of HF, which may be a new therapeutic and diagnostic target, representing a new class of therapeutic strategies.https://doi.org/10.1186/s13578-023-01066-8EpigeneticsHepatic fibrosisRNA methylationN6-methyladenosineHepatic stellate cells
spellingShingle Chenglong Cheng
Yajie Wu
Xin Wang
Qiuyun Xue
Yurong Huang
Faxue Liao
Xiao Wang
Qiangjun Duan
Chenggui Miao
RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
Cell & Bioscience
Epigenetics
Hepatic fibrosis
RNA methylation
N6-methyladenosine
Hepatic stellate cells
title RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
title_full RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
title_fullStr RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
title_full_unstemmed RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
title_short RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
title_sort rna methylations in hepatic fibrosis a gradually emerging new treatment strategy
topic Epigenetics
Hepatic fibrosis
RNA methylation
N6-methyladenosine
Hepatic stellate cells
url https://doi.org/10.1186/s13578-023-01066-8
work_keys_str_mv AT chenglongcheng rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT yajiewu rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT xinwang rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT qiuyunxue rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT yuronghuang rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT faxueliao rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT xiaowang rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT qiangjunduan rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy
AT chengguimiao rnamethylationsinhepaticfibrosisagraduallyemergingnewtreatmentstrategy